William Demant Invest


The William Demant Foundation’s investment activities are handled by William Demant Invest, which is fully owned by the Foundation. In addition to its shareholding of 55-60% in Demant A/S, William Demant Invest also has owner’s shares of 52% in the Islandic prosthesis company Össur hf., 42% in the real-estate and service company Jeudan A/S, 24% in the IVF treatment company Vitrolife AB, 12% in the hematology company CellaVision and 89% in the English medico company Vision RT.

Read more about William Demant Invest here.